I would say the man is correct we he says orphan drug status is vital , as phase III trials will take a fair while to run and require at least 300 patients.
Facts only not a ramp in either direction.
If I'm wrong tell me so and provide the evidence to prove it.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $379.7M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 25.5¢ | $78.70K | 302.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 283059 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 196 | 1 |
View Market Depth
| Last trade - 10.02am 21/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |